| Literature DB >> 30993545 |
Jaruwan Satjanadumrong1, Matthew T Robinson2,3, Tom Hughes1,4, Stuart D Blacksell5,6,7.
Abstract
Spotted fever group and related rickettsia (SFGR) are a neglected group of pathogens that belong to the genus Rickettsia. SFGR are zoonotic and are transmitted by arthropod vectors, primarily ticks, fleas and mites to accidental hosts. These emerging and re-emerging infections are widely distributed throughout the world. Land-use change and increasing human-wildlife conflict compound the risk of SFGR infection to local people in endemic areas and travelers to these regions. In this article, we discuss the rickettsial organisms causing spotted fever and related diseases, their arthropod vectors in Asia and the impact of land-use change on their spread.Entities:
Keywords: Asia; Diagnosis; Land-use change; Rickettsial infection; Spotted fever rickettsia
Mesh:
Year: 2019 PMID: 30993545 PMCID: PMC6910891 DOI: 10.1007/s10393-019-01409-3
Source DB: PubMed Journal: Ecohealth ISSN: 1612-9202 Impact factor: 3.184
Reports of spotted fever group Rickettsia spp. organisms and antibodies in humans, animals and arthropod vectors in Asia.
| Countries | Rickettsia species | Arthropod vectors | Hosts | References |
|---|---|---|---|---|
| Cambodia | NA | Human, Dogs | Inpankaew et al. ( | |
| China | Sheep | Wei et al. ( | ||
| Sheep | Wei et al. ( | |||
| Sheep | Guo et al. ( | |||
| Sheep | Guo et al. ( | |||
| NA | Sun et al. ( | |||
| NA | Sun et al. ( | |||
| NA | Sun et al. ( | |||
| NA | Human (serum) | Li et al. ( | ||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Liu et al. ( | |||
| NA | Liu et al. ( | |||
| NA | Zhang et al. ( | |||
| NA | Zhang et al. ( | |||
| NA | Zhang et al. ( | |||
| NA | Zhang et al. ( | |||
| NA | Zhang et al. ( | |||
| NA | Zhang et al. ( | |||
| Dog | Zhang et al. ( | |||
| NA | Human, Mice spleen | Zhang et al. ( | ||
| NA | Yang et al. ( | |||
| Sheep | Guo et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA | Han et al. ( | |||
| NA, Human (serum) | Han et al. ( | |||
| Hong Kong | Cats | Slapeta et al. ( | ||
| NA | Human | Ma et al. ( | ||
| India | Human | Kalal et al. ( | ||
| Indonesia | Rat and shrew | Barbara et al. ( | ||
| NA | Human (blood) | Richards et al. ( | ||
| NA | Human (blood) | Richards et al. ( | ||
| Japan | NA NA | Fournier et al. ( | ||
| NA | Dog (serum) | Satoh et al. ( | ||
| NA | Fournier et al. ( | |||
| NA | Fournier et al. ( | |||
| NA | Ishiguro et al. ( | |||
| NA | Ishiguro et al. ( | |||
| NA | Ishiguro et al. ( | |||
| NA | Ishiguro et al. ( | |||
| Human | Imaoka et al. ( | |||
| Korea | NA | Human (serum) | Choi et al. ( | |
| NA | Human (serum) | Choi et al. ( | ||
| NA | Human (serum) | Choi et al. ( | ||
| NA | Human (serum) | Choi et al. ( | ||
| NA | Lee et al. ( | |||
| NA | Lee et al. ( | |||
| NA | Noh et al.( | |||
| NA | Noh et al.( | |||
| NA | Noh et al.( | |||
| Mice | Noh et al. ( | |||
| NA | Noh et al. ( | |||
| Laos | NA | Human (serum) | Phongmany et al. ( | |
| NA | Human (serum) | Phongmany et al. ( | ||
| NA | Human (serum) | Phongmany et al. ( | ||
| Dog | Varagnol et al. ( | |||
| Cat & Dog | Varagnol et al. ( | |||
| Dog | Varagnol et al. ( | |||
| NA | Human | Dittrich et al. ( | ||
| NA | Taylor et al. ( | |||
| NA | Taylor et al. ( | |||
| NA | Taylor et al. ( | |||
| NA | Taylor et al. ( | |||
| NA | Taylor et al. ( | |||
| NA | Taylor et al. ( | |||
| NA | Taylor et al. ( | |||
| NA | Taylor et al. ( | |||
| Malaysia | NA | Human | Tay et al. ( | |
| NA | Rat | Tay et al. ( | ||
| Sheep | Kho et al. ( | |||
| NA | Tay et al. ( | |||
| NA | Human | Kho et al. ( | ||
| NA | Tay et al. ( | |||
| NA | Human | Kho et al. ( | ||
| Cat | Kho et al. ( | |||
| NA | Monkeys (blood) | Tay et al. ( | ||
| Philippines | NA | Human | Camer et al. ( | |
| Sri Lanka | NA | Human | Nanayakkara et al. ( | |
| NA | Human | Nagalingam et al. ( | ||
| NA | Human | Angelakis et al. ( | ||
| Thailand | NA | Rats (serum) | Okabayashi et al. ( | |
| NA | Human (serum) | Edouard et al. ( | ||
| Rat | Kollars et al. ( | |||
| NA | Rat (serum) | Okabayashi et al. ( | ||
| NA | Human (serum) | Edouard et al. ( | ||
| NA | Human (serum) | Parola et al. ( | ||
| NA | Human (serum) | Parola et al. ( | ||
| Bear | Parola et al. ( | |||
| Wild pig | Parola et al. ( | |||
| NA | Human | Parola et al. ( | ||
| NA | Human | Parola et al. ( | ||
| NA | Human | Parola et al. ( | ||
| Taiwan | NA | Tsui et al. ( | ||
| NA | Tsui et al. ( | |||
| NA | Tsui et al. ( | |||
| Rodent | Kuo et al. ( | |||
| NA | Rodent | Kuo et al. ( | ||
| NA | Rodent | Kuo et al. ( | ||
| NA | Rodent | Kuo et al. ( | ||
| Bird | Kuo et al. ( |
NA not available.
Figure 1Geographical distribution of reported detections of spotted fever group Rickettsia spp. organisms and antibodies in humans, animals and arthropod vectors in Asia.
Spotted fever group rickettsia seroprevalence studies in Asia.
| Year | Country | Human sample no. | Method | Diagnostic cutoff | SFGR prevalence | Rickettsial species | References |
|---|---|---|---|---|---|---|---|
| 1992–1998, 2001 | Philippines | 157 | IFA | ≥ 1:64 | 1.3% | Camer et al.( | |
| 1992–1993 | South Korea | 3362 | IFA | 1:40 | 38.6% | Jang et al. ( | |
| 1994–1999 | Malaysia | 61,501 | IIP | ≥ 1:50 (IgM/IgG) | 12.9% | TT-118 | Tay and Rohani ( |
| 1996–1997 | Malaysia | 300 | IIP | ≥ 1:50 (IgM/IgG) | 57.3% | TT-118 | Tee et al. ( |
| 2000–2001 | Sri Lanka | 60 | IFA | > 20–5120, > 100 (IgM/IgG) | 35% | Kularatne et al. ( | |
| 2002–2003 | Sri Lanka | 31 | IFA | 4-fold rise | 28% | SFGR | Premaratna et al. ( |
| 2002–2007 | Sri Lanka | 105 | IFA | 1:256 (IgG) | 40.9% | Kularatne et al. ( | |
| 2008 | Sri Lanka | 50 | IFA | ≥ 1:64 (IgG) | 66% | SFGR | Premaratna et al. ( |
| 2002–2005 | Thailand | 2225 | IFA | ≥ 1:128 (IgG) ≥ 1:64 (IgM) | 0.8% | SFGR | Bhengsri et al. ( |
| 2004–2009 | Taiwan | 413 | IFA | ≥ 1:40 | 11.4% (IgG) 1% (IgM) | Lai et al. ( | |
| 2008–2009 | Bangladesh | 720 | IFA | ≥ 1:64 | 18% | SFGR | Faruque et al. ( |
| 2009 | Central India | 161 | ELISA | ≥ 1:64 (IgM) | 69.3% | SFGR | Rathi et al. ( |
| 2010–2012 | South India | 103 | ELISA | Index value > 11 (IgG) | 37.1% | SFGR | (Kalal et al. |
| 2011–2012 | Vietnam | 908 | ELISA | OD ≥ 0.5 | 1.7% | SFGR | Trung et al. ( |
| 2013–2015 | Northeast India | 1265 | ELISA | OD ≥ 0.5 | 13.8% | SFGR | Khan et al. ( |